BACM
INFI

Blue Arrow Capital Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Blue Arrow Capital Management’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-32,000
Closed -$408K – 217
2014
Q2 		$408K Sell
32,000
-23,000
-42% -$240K 0.05% 122
2014
Q1 		$654K Buy
+55,000
New +$738K 0.1% 92

Other funds holding INFI

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Blue Arrow Capital Management's INFI Position: Q3 2014 in Review

Blue Arrow Capital Management sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2014, closing a stake of 32,000 shares — an estimated $408K sold.

Blue Arrow Capital Management first reported a position in INFI in Q1 2014 and held it in 2 quarters. The position peaked at $654K in Q1 2014. 118 funds tracked by Wall St. Rank hold INFI as of Q3 2014.

  • Blue Arrow Capital Management reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2014 after selling out during the quarter.
  • Blue Arrow Capital Management sold 32,000 Infinity Pharmaceuticals, Inc. shares in Q3 2014, an estimated $408K.
  • Blue Arrow Capital Management first reported a position in Infinity Pharmaceuticals, Inc. in Q1 2014 and held it in 2 quarters.
  • Blue Arrow Capital Management's Infinity Pharmaceuticals, Inc. position peaked at $654K in Q1 2014.
  • 118 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2014.

Based on Blue Arrow Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.